Oncotype DX®

The only test in the world that predicts
patient's response to chemotherapy
in early breast cancer


A pioneering test for the early detection and early diagnosis of pancreatic cancer


Molecular detection of minimal residual disease in blood


Multi-gene test for Hereditary Cancer
(Including BRCA1 & BRCA2 genes)

Com.pl.i.t DX®

Personalised treatment based on tumour biology For patients with lung, colorectal and breast cancer

Prime DX

Precision Individualized Medicine

For an effective personalised treatment plan for cancer


Use the platform in order to learn how molecular diagnostics can be an invaluable tool in the treatment or patient management decision making process.